GLA:D® steht für Good Life with osteoArthritis in Denmark und wurde 2013 in Dänemark eingeführt mit dem Ziel, internationale Best Practice Richtlinien in der Praxis umzusetzen.
In 5 Jahren haben knapp 38’000 Patient*innen mit Knie- oder Hüftarthrose das Programm absolviert. Der Effekt des Programms wird kontrolliert und die Resultate zeigen: Schmerzreduktion, verbesserte Lebensqualität, weniger Schmerzmittel und weniger Absenzen am Arbeitsplatz.
Verantwortlich für GLA:D® Dänemark sind Ewa M. Roos und Søren T. Skou.
EWA M. ROOS
Department of Sports Science and Clinical Biomechanics, University of Southern Denmark
Verantwortliche für GLA:D® Dänemark
«Us researchers have known for many years that exercise is good medicine for people with osteoarthritis. This is what we find when the many randomized studies are summarized, and therefore treatment guidelines around the world recommend patient education, exercise and weight loss, if needed, as first treatment for people with osteoarthritis.
We started GLA:D® to help clinicians deliver evidence-based treatment to people with osteoarthritis. It has become a success. Not only in Denmark but also in Canada, Australia and China.
The average of the until now 38.000 osteoarthritis patient participating in Denmark experience a 25% pain reduction and walk 10% faster after 8 weeks. It is very rewarding to help people help themselves to a better quality of life. And to find an alternative to pills and surgery that also helps improve general health.»
SØREN T. SKOU
Associate Professor, Research Unit for Musculoskeletal Function and Physiotherapy, University of Southern Denmark
Verantwortlicher für GLA:D® Dänemark
«Despite strong supporting evidence, only about one out of three patients with osteoarthritis received exercise and education for their joint pain. In order to change this, we started Good Life with osteoArthritis in Denmark (GLA:D®), which supports clinicians worldwide to deliver evidence-based treatment for the benefit of the individual patient.
So far GLA:D® has helped several thousands of patients reduce their pain and improve their function, both after the treatment program and in the long-term. Furthermore, fewer patients are taking painkillers and fewer patients are on sick leave, suggesting further individual and societal benefits.»